Clinical Trials Browser

OTHER_GOV × Gynecologic × 30 days × Clear all

NCT07472140 2026-03-16

PARP (Poly (ADP-ribose) Polymerase) Inhibitor With or Without Angiogenesis Inhibitor in Homologous Recombination Deficient Primary Ovarian Cancer, Fallopian-Tube Cancer, or Primary Peritoneal Cancer

Phase 2/3 Recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT07472153 2026-03-16

PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer

Phase 2/3 Recruiting

Uterine Cervical Neoplasms

NCT07431788 2026-03-03

UMAH

Phase NA Recruiting

Leiomyoma, Uterine Hemorrhage

NCT07435623 2026-03-02

Late Radiation Toxicities in Cervical and Endometrial Cancer: A Postoperative IMRT/Brachytherapy Study

Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT06839157 2026-02-25

Artificial Intelligence - Assisted Model for Optimal Timing of Surgery in Advanced Ovarian Cancer

Active not recruiting

Ovarian, Fallopian, and Primary Peritoneal Cancer

NCT03005743 2026-02-23

COMBAT-Cx

Phase NA Completed

Uterine Cervical Neoplasms

NCT05102240 2026-02-20

Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix Cancer

Uterine Cervical Neoplasms

NCT06264167 2026-02-20

NODE

Phase NA Recruiting

Lymphatic Metastasis, Vulvar Neoplasms

NCT06644846 2026-02-20

Spatially Fractionated Radiation Treatment for Gynaecological Cancers

Phase NA Recruiting

Uterine Cervical Neoplasms, Neoplasms, Recurrence